Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (27 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Patient service revenue
0
60
181
187
193
Provision for doubtful accounts related to patient service revenue
0
-1
-3
-3
-6
Net patient service revenue
0
59
178
184
187
Capitated revenue
4
1
10
67
96
Management and other services revenue
23
23
26
23
21
Lithotripsy revenue
22
22
21
22
21
Net operating revenue
49
106
235
295
325
Salaries, wages and employee benefits
20
63
154
166
169
Medical services and supplies expense
0
7
29
80
106
Rent expense
0
5
15
16
18
Provision for doubtful accounts
0
0
0
0
0
Other operating expenses
8
16
28
33
40
Electronic Health Record incentive income
0
0
-2
0
0
Impairment of goodwill
0
0
0
20
0
Depreciation and amortization
1
3
8
16
9
Total operating expenses
30
93
232
332
342
Loss from operations
19
12
3
-37
-17
Interest expense, net
-1
-1
-2
-3
-4
Equity in income of nonconsolidated affiliates, net
2
4
10
12
10
Recovery of investments in nonconsolidated affiliates
-1
0
0
0
0
Other gain (loss), net
0
0
0
0
18
Total other income, net
0
3
8
8
25
INCOME (LOSS) BEFORE INCOME TAXES
19
15
11
-28
8
Provision (benefit) for income taxes
3
1
0
-6
0
Net Income (Loss)
16
14
11
-23
8
Less: Net income attributable to noncontrolling interests
-13
-12
-10
-10
-10
Net income (loss) attributable to USMD Holdings, Inc.
3
2
1
-32
-2
Remarks
restated on Apr 1, 2013 n/a
calculated values,
restated on Apr 15, 2014 n/a
calculated values,
restated on Apr 15, 2015 n/a
calculated values,
restated on Apr 14, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (42 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Assets
Cash and cash equivalents
11
7
13
16
30
Restricted cash
0
5
5
0
10
Accounts receivable, net of allowances
5
21
24
25
23
Inventories
0
1
2
3
2
Deferred tax assets, net
0
1
1
6
6
Prepaid expenses and other current assets
0
3
3
4
5
Total current assets
16
37
48
53
76
Property and equipment, net
3
26
23
21
29
Investments in nonconsolidated affiliates
12
36
62
60
69
Goodwill
8
118
118
98
90
Intangible assets, net
0
29
27
17
15
Other assets
0
0
0
0
0
Deferred tax assets
1
0
0
0
0
Total assets
40
246
279
249
279
Liabilities and owners' equity
Accounts payable
0 243000
3 3318000
3 2500000
8 7708000
8 7614000
Accrued payroll
2 1534000
10 9813000
13 12599000
14 13816000
11 11336000
Other accrued liabilities
3 2742000
6 5867000
11 10757000
18 18373000
21 21388000
Other current liabilities
0 278000
1 1115000
1 1059000
1 606000
1 604000
Revolving credit facility
0 0
0 0
0 0
0 0
0 0
Current portion of long-term debt
1 886000
5 4639000
7 7473000
2 2040000
7 7121000
Current portion of related party long-term debt
0 469000
1 594000
1 650000
1 746000
0 0
Current portion of capital lease obligations
0 239000
0 287000
0 369000
1 537000
1 1486000
Total current liabilities
6 6391000
26 25633000
35 35407000
44 43826000
50 49549000
Other long-term liabilities
1 1057000
1 1300000
1 1485000
2 1888000
10 10120000
Deferred compensation payable
0 0
5 4898000
5 4641000
4 4491000
4 4275000
Long-term debt, less current portion
0 0
17 16754000
34 33939000
28 28264000
27 26741000
Related party long-term debt, less current portion
7 6789000
4 3734000
3 3084000
3 3085000
15 15421000
Capital lease obligations, less current portion
1 821000
1 561000
1 683000
2 1789000
6 6049000
Deferred tax liabilities, net
4 3914000
24 23789000
24 24359000
20 20127000
15 15281000
Total liabilities
19 18972000
77 76669000
104 103598000
103 103470000
127 127436000
Commitments and contingencies
0 0
0 0
0 0
0 0
0 0
Preferred stock
0 0
0 0
0 0
0 0
0 0
Common stock
0 36000
0 100000
0 101000
0 102000
0 113000
Additional paid-in capital
8 7678000
153 153444000
158 158360000
160 160458000
171 171269000
Accumulated deficit
11 10571000
13 12671000
14 13650000
-19 -18750000
-20 -20366000
Accumulated other comprehensive loss
0 -19000
0 -16000
0 -2000
0 -2000
0 -2000
Treasury stock at cost
-1 -1184000
0 0
0 0
0 0
0 0
Total USMD Holdings, Inc. stockholders' equity
17 17082000
166 166199000
172 172109000
142 141808000
151 151014000
NONCONTROLLING INTERESTS IN SUBSIDIARIES
4 4366000
3 3248000
3 3416000
3 3370000
0 100000
Total equity
21 21448000
169 169447000
176 175525000
145 145178000
151 151114000
Total liabilities and equity
40 40420000
246 246116000
279 279123000
249 248648000
279 278550000
Remarks restated on Apr 1, 2013 n/a restated on Apr 15, 2014 n/a restated on Apr 15, 2015 n/a restated on Nov 30, -1 n/a restated on Aug 12, 2016 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (45 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Net Income (Loss)
16
14
11
-23
8
Provision for doubtful accounts
0
1
3
4
6
Depreciation and amortization
1
3
8
16
9
Accretion of debt discount and amortization of debt issuance costs
0
1
0
1
1
Loss on extinguishment of debt
0
0
0
0
0
(Gain) loss on sale or disposal of assets, net
0
0
0
0
0
Gain on sale of ownership interest in nonconsolidated affiliate
0
0
0
0
0
Gain on sale of Lithotripsy Services business
0
0
0
0
-12
Gain on deconsolidation of partnership
0
0
0
0
-6
Impairment of goodwill
0
0
0
20
0
Equity in income of nonconsolidated affiliates, net
-2
-4
-10
-12
-10
Distributions from nonconsolidated affiliates
1
2
8
14
8
Share-based payment expense
1
1
2
2
8
Recovery of investments in nonconsolidated affiliates
1
0
0
0
0
Deferred income tax benefit
0
1
-1
-9
-1
Accounts receivable
0
-2
-6
-4
-7
Inventories
0
0
-1
-1
0
Prepaid expenses and other assets
0
-1
-1
-1
0
Accounts payable
0
0
-1
5
0
Accrued and other current liabilities
1
-9
8
8
3
Other noncurrent liabilities
0
0
0
0
2
Net cash provided by operating activities
18
6
21
21
9
Cash paid for business combinations, net of cash acquired
0
7
0
0
0
Proceeds from sale of Lithotripsy Services business, net of cash included in sale
0
0
0
0
8
Decrease in cash due to deconsolidation of partnership
0
0
0
0
0
Capital expenditures
0
-1
-3
-2
-4
Proceeds from sale of life insurance policies
0
3
0
0
0
Payments received for the sale of ownership interests in nonconsolidated affiliates
0
0
0
0
0
Proceeds from sale of property and equipment
0
0
0
0
0
Increase in cash due to initial consolidation of investee
0
0
0
0
0
Net cash provided by (used in) investing activities
-1
9
-3
-2
4
Proceeds from issuance of long-term debt
0
21
1
7
4
Proceeds from issuance of related party long-term debt
0
0
0
0
15
Repayments of borrowings under revolving credit facility
0
0
3
-3
0
Payments on long-term debt and capital lease obligations
0
-21
-5
-16
-2
Principal payments on related party long-term debt
0
-3
-1
0
-1
Issuance of USMD common stock
0
1
0
0
0
Payment of debt issuance costs
0
0
0
0
0
Proceeds from exercise of stock options
0
0
0
0
0
Capital contributions from noncontrolling interests
0
1
1
0
0
Distributions to noncontrolling interests
-13
-13
-10
-10
-9
Release (restriction) of restricted cash
0
-5
0
5
-7
Net cash provided by (used in) financing activities
-14
-19
-12
-17
0
Net increase in cash and cash equivalents
3
-4
6
3
14
Remarks
restated on Apr 1, 2013 n/a
calculated values,
restated on Apr 15, 2014 n/a
calculated values,
restated on Apr 15, 2015 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,